Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)

Organon

Status and phase: Completed; Phase 3

Conditions: Asthma

Treatments: Drug: Comparator: placebo / Duration of Treatment: 4 weeks; Drug: MK0476, montelukast sodium / Duration of Treatment: 4 weeks

Study type: Interventional

Funder types: Industry

Identifiers

NCT00092144

2004_028

0476-289

Details and patient eligibility

About

The purpose of this study is to assess the efficacy and safety of an approved drug on asthma symptoms in patients with chronic asthma which is also active during the allergy season.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Asthma symptoms brought on by allergies

Exclusion criteria

• Patient has any lung disease
• Currently have a sinus infection or cold symptoms

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind